There are some incredible deals in biotech that have been overlooked by investors. Hemostemix (HMTXF: OTCMKTS) has award-winning technology in stem cell...
Vaccines have less efficacy with COVID-19 variants Key 3CL protease inhibitors shows promise for any COVID-19 variants, and potentially all coronav...
Bioxytran Inc. (OTCMKTS: BIXT) has a development stage hypoxia drug that that was initially targeting Acute Respiratory Distress Syndrome (ARDS) an...